Edition:
United Kingdom

ENDRA Life Sciences Inc (NDRA.OQ)

NDRA.OQ on NASDAQ Stock Exchange Capital Market

2.51USD
9:00pm BST
Change (% chg)

$0.04 (+1.62%)
Prev Close
$2.47
Open
$2.50
Day's High
$2.51
Day's Low
$2.36
Volume
6,640
Avg. Vol
13,558
52-wk High
$5.88
52-wk Low
$1.57

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.01 -0.720
FY 2017 Dec '17 0.01 -0.585
Sep '17 0.29 -0.233
Jun '17 0.06 -0.588
Mar '17 0.00 -0.190
FY 2016 Dec '16 0.52 -0.189
Sep '16 0.00 -1.352
Jun '16 0.00 -0.200
Mar '16 0.00 -0.104
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 82.81 32.74
P/E High - Last 5 Yrs. -- 289.15 45.73
P/E Low - Last 5 Yrs. -- 90.24 24.23
Beta -- 0.91 0.88
Price to Sales (TTM) 22.56 109.18 5.71
Price to Book (MRQ) 1.66 13.44 5.37
Price to Tangible Book (MRQ) 1.66 13.96 6.94
Price to Cash Flow (TTM) -- 70.39 23.32
% Owned Institutions 11.05 13.84 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.34 1.50
Dividend Yield - 5 Year Avg -- 0.25 1.51
Dividend 5 Year Growth Rate -- 1.64 5.32
Payout Ratio(TTM) -- 15.83 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 392.54 7.89
Sales (TTM) vs TTM 1 Yr. Ago -1.33 77.35 5.68
Sales - 5 Yr. Growth Rate -- 32.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -193.33 24.53 19.38
EPS (TTM) vs TTM 1 Yr. Ago -113.28 -- --
EPS - 5 Yr. Growth Rate -- 39.08 10.78
Capital Spending - 5 Yr. Growth Rate -- 40.34 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 46.45 1.83 2.19
Current Ratio (MRQ) 47.27 5.26 2.98
LT Debt to Equity (MRQ) 0.00 24.54 12.19
Total Debt to Equity (MRQ) 0.00 26.17 16.46
Interest Coverage (TTM) -- -97.42 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 49.89 40.81 54.46
Gross Margin - 5 Yr. Avg. -- 51.76 52.22
EBITD Margin (TTM) -396.30 -- --
EBITD - 5 Yr. Avg -- -564.12 10.98
Operating Margin (TTM) -408.57 -706.11 4.74
Operating Margin - 5 Yr. Avg. -- -585.15 6.41
Pre-Tax Margin (TTM) -669.78 -681.03 5.58
Pre-Tax Margin - 5 Yr. Avg. -- -588.45 6.83
Net Profit Margin (TTM) -669.78 -682.46 1.88
Net Profit Margin - 5 Yr. Avg. -- -591.46 3.10
Effective Tax Rate (TTM) -- 22.64 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.26 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 114,670 22,312,275 846,855,612
Net Income/Employee (TTM) -768,038 2,947,385 99,619,380
Receivable Turnover (TTM) -- 19.92 5.78
Inventory Turnover (TTM) 3.71 2.37 3.35
Asset Turnover (TTM) 0.13 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -87.99 -0.70 10.95
Return on Assets - 5 Yr. Avg. -- -0.06 12.32
Return on Investment (TTM) -95.41 2.00 14.38
Return on Investment - 5 Yr. Avg. -- 2.81 16.11
Return on Equity (TTM) -95.41 3.49 16.08
Return on Equity - 5 Yr. Avg. -- 4.33 17.41
  1 Year 3 Year 5 Year
Sales % -63.44 -- --
EPS (TTM) % -21.77 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ENDRA Life Sciences Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 12.81%
# of Holders: 6
Total Shares Held: 502,691
3 Mo. Net Change: 48,024
# New Positions: 3
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 0
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.